Christopher W. Dicus

Phenylglycine and Sulfonamide Correctors of Defective ΔF508 and G551D Cystic Fibrosis Transmembrane Conductance Regulator Chloride-Channel Gating

Nicoletta Pedemonte, N.D. Sonawane, Alessandro Taddei et al. · Molecular Pharmacology · 2005 · 140 citations

Delivery of antioxidative enzyme genes protects against ischemia/reperfusion–induced liver injury in mice

Song-Qing He, Yan-Hong Zhang, Senthil Kumar Venugopal et al. · Liver Transplantation · 2006 · 108 citations · Full text

Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: towards a pharmacophore model for the nucleotide-binding domain

Mark F. Springsteel, Luis J. V. Galietta, Tonghui Ma et al. · Bioorganic & Medicinal Chemistry · 2003 · 64 citations

Molecular Pharmacology, Benzoflavone Activators, Molecular Physiology +10

The Benefit of Hydrophobic Domain Asymmetry on the Efficacy of Transfection as Measured by <i>in Vivo</i> Imaging

Michael H. Nantz, Christopher W. Dicus, Brendan Hilliard et al. · Molecular Pharmaceutics · 2010 · 34 citations

Lipid Preparation, Tissue Imaging, Engineering +15

Dolastatin 11 Connects Two Long-pitch Strands in F-actin to Stabilize Microfilaments

Toshiro Oda, Z. Crane, Christopher W. Dicus et al. · Journal of Molecular Biology · 2003 · 30 citations

Mechanobiology, Long-pitch Strands, Dolastatin 11 +8